UPDATED May 14, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IBNSINA | ৳250.00 | -1.8% | -12.8% | ৳7.8b | ৳390.00 | PE12x | E19.2% | 2.4% | Pharmaceuticals & Biotech |